BioNTech SE (BNTX) Tax Provisions (2018 - 2025)

BioNTech SE (BNTX) has 8 years of Tax Provisions data on file, last reported at -$90.3 million in Q4 2025.

• In Q4 2025, Tax Provisions fell 102.71% year-over-year to -$90.3 million; the TTM figure through Dec 2025 stood at -$77.3 million (down 257.92% YoY), while the FY2025 annual figure was $96.4 million, up 827.31% from the prior year.
• Tax Provisions fell to -$90.3 million in Q4 2025, from $62.4 million in the prior quarter.
• Across five years, Tax Provisions topped out at $1.5 billion in Q2 2021 and bottomed at -$1.8 billion in Q4 2021.
• A 5-year average of $67.1 million and a median of $20.6 million in 2024 frame the typical range for Tax Provisions.
• The widest YoY moves for Tax Provisions: up 61306.0% in 2021, down 920630837.69% in 2021.
• Year by year, Tax Provisions stood at -$1.8 billion in 2021, then jumped by 151.51% to $912.0 million in 2022, then plunged by 124.22% to -$220.9 million in 2023, then soared by 79.83% to -$44.6 million in 2024, then plunged by 102.71% to -$90.3 million in 2025.
• The last three Tax Provisions figures came in at -$90.3 million (Q4 2025), $62.4 million (Q3 2025), and -$18.2 million (Q2 2025), per Business Quant data.

Peer Comparison